Advertisement
Advertisement
ACB
Aurora Cannabis Inc. Common Shares
3.38
USDSponsored
-0.08
-2.17%
Mar 19, 15:59 UTC -4
Closed
After-Market
3.44
+0.06
+1.77%
ACB Earnings Reports
Positive Surprise Ratio
ACB beat 11 of 36 last estimates.
31%
Next Report
Date of Next Report
Jun 16, 2026
Estimate for Q4 26 (Revenue/ EPS)
$82.05M
/-$0.05
Implied change from Q3 26 (Revenue/ EPS)
-12.89%
/-266.67%
Implied change from Q4 25 (Revenue/ EPS)
-9.38%
/-88.64%
Aurora Cannabis Inc. Common Shares earnings per share and revenue
On Feb 04, 2026, ACB reported earnings of 0.03 USD per share (EPS) for Q3 26, missing the estimate of 0.21 USD, resulting in a -86.02% surprise. Revenue reached 94.19 million, compared to an expected 93.30 million, with a 0.96% difference. The market reacted with a -7.64% price change (close before vs. close after earnings).
Looking ahead to Q4 26, 4 analysts forecast an EPS of -0.05 USD, with revenue projected to reach 82.05 million USD, implying an decrease of -266.67% EPS, and decrease of -12.89% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Capricor Therapeutics Inc
Report Date
Mar 12, 2026 For Q4 25
Estimate
-$0.55
Actual
-$0.62
Surprise
-12.56%
Kestra Medical Technologies, Ltd. Common Stock
Report Date
Mar 17, 2026 For Q3 26
Estimate
-$0.60
Actual
-$0.61
Surprise
-0.39%
Brainsway Ltd. - ADR
Report Date
Mar 11, 2026 For Q4 25
Estimate
$0.13
Actual
$0.26
Surprise
+98.02%
Sundial Growers Inc. Common Shares
Report Date
Mar 12, 2026 For Q4 25
Estimate
-$0.01
Actual
$0.04
Surprise
+499.62%
High Tide Inc. Common Shares
Report Date
Mar 17, 2026 For Q1 26
Estimate
$0.00
Actual
$0.01
Surprise
+447.68%
MacroGenics, Inc.
Report Date
Mar 09, 2026 For Q4 25
Estimate
-$0.29
Actual
-$0.23
Surprise
+22.40%
Apyx Medical Corporation Common Stock
Report Date
Mar 10, 2026 For Q4 25
Estimate
-$0.05
Actual
-$0.03
Surprise
+48.63%
Exagen Inc. Common Stock
Report Date
Mar 10, 2026 For Q4 25
Estimate
-$0.19
Actual
-$0.20
Surprise
-4.22%
Biote Corp. Class A Common Stock
Report Date
Mar 11, 2026 For Q4 25
Estimate
$0.05
Actual
$0.06
Surprise
+17.65%
Nephros Inc.
Report Date
Mar 12, 2026 For Q4 25
Estimate
$0.01
Actual
$0.08
Surprise
+684.31%
FAQ
What were Aurora Cannabis Inc. Common Shares's earnings and revenue for the latest quarter Q3 2026?
For Q3 2026, Aurora Cannabis Inc. Common Shares reported EPS of $0.03, missing estimates by -86.02%, and revenue of $94.19M, 0.96% above expectations.
How did the market react to Aurora Cannabis Inc. Common Shares's Q3 2026 earnings?
The stock price moved down -7.64%, changed from $4.06 before the earnings release to $3.75 the day after.
When is Aurora Cannabis Inc. Common Shares expected to report next?
The next earning report is scheduled for Jun 16, 2026.
What are the forecasts for Aurora Cannabis Inc. Common Shares's next earnings report?
Based on 4
analysts, Aurora Cannabis Inc. Common Shares is expected to report EPS of -$0.05 and revenue of $82.05M for Q4 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement